US stock futures flat after Wall St drops on Trump tariffs, soft jobs data
Eric P. Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), sold 155,940 shares of Class A Common Stock on July 28, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sales were executed at prices ranging from $62.16 to $65.23, resulting in a total transaction value of $10,452,026. The stock, currently trading at $57.89, has declined nearly 9% over the past week. According to InvestingPro analysis, Tempus AI appears overvalued at current levels.
The filing indicates that the sales were conducted indirectly through entities including Gray Media, LLC and Blue Media, LLC. Lefkofsky is the sole manager of Black Media, LLC, Blue Media, LLC and Gray Media, LLC.
Following the reported transactions, Lefkofsky continues to indirectly hold a significant number of Tempus AI shares through various entities and trusts.
In other recent news, Tempus AI, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECG-Low EF software. This AI-powered software is designed to identify patients with a low left ventricular ejection fraction, a condition that can indicate serious cardiovascular issues. This marks the second FDA-cleared ECG-AI device in Tempus’ cardiovascular diagnostic portfolio. Additionally, Tempus AI announced the expansion of its Tempus Next (LON:NXT) care pathway intelligence platform to include support for breast cancer, aiming to address biomarker testing gaps and improve guideline-directed medical care.
In financial developments, Tempus AI has proposed a $400 million convertible senior notes offering due in 2030. The company plans to use part of the proceeds to repay outstanding term loans, including a $275 million loan due in 2027, to reduce interest expenses and enhance financial flexibility. The offering also includes an option for initial purchasers to buy an additional $60 million in notes. Proceeds will also fund capped call transactions to reduce potential dilution and support general corporate purposes. These recent developments reflect Tempus AI’s ongoing efforts to expand its technological capabilities and financial strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.